T
The Eye Institute of West Florida | Largo
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Dexamethasone
PG324
EYP-1901
Aflibercept
DYME
riboflavin
Abicipar Pegol
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 13 total trials
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Enrolling
Wet Age Related Macular Degeneration
wAMD
Drug: Aflibercept (2.0 mg)
Drug: EYP-1901
This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angl...
Begins enrollment this month
Open Angle Glaucoma
Ocular Hypertension
Drug: Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution
Drug: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution
Trial sponsors
A
C
E
E
R
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems